Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jialie Jin"'
Autor:
Lanfei Bi, Jialie Jin, Yao Fan, Yu Liu, Haifeng Xu, Mengxia Li, Changying Chen, Chong Shen, Rongxi Yang
Publikováno v:
Clinical Epigenetics, Vol 16, Iss 1, Pp 1-14 (2024)
Abstract Background Coronary heart disease (CHD) and stroke have become the leading cause of premature mortality and morbidity worldwide. Therefore, sensitive and accurate biomarkers for early detection of CHD and stroke are urgently needed for effec
Externí odkaz:
https://doaj.org/article/018fa79381d8444ea325563146ee335e
Autor:
Jialie Jin, Xiaojing Zhao, Chao Zhu, Mengxia Li, Jinxin Wang, Yao Fan, Chunlan Liu, Chong Shen, Rongxi Yang
Publikováno v:
Clinical Epigenetics, Vol 15, Iss 1, Pp 1-13 (2023)
Abstract Background Novel molecular biomarkers for the risk assessment and early detection of coronary heart disease (CHD) are urgently needed for disease prevention. Altered methylation of ATP-binding cassette subfamily G member 1 (ABCG1) has been i
Externí odkaz:
https://doaj.org/article/53133ab24bb24dbda42946ac4057e32b
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundCoronary heart disease (CHD) brings a heavy burden to society worldwide. Novel and minimally invasive biomarkers for the risk evaluation of CHD are urgently needed. Previous study has revealed that blood-based hypomethylation of β-actin (A
Externí odkaz:
https://doaj.org/article/4d1bf82fff7f43efbe843c46d83c6904
Autor:
Chunlan Liu, Xiajie Zhou, Jialie Jin, Qiang Zhu, Lixi Li, Qiming Yin, Tian Xu, Wanjian Gu, Fei Ma, Rongxi Yang
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Recent studies have identified DNA methylation signatures in the white blood cells as potential biomarkers for breast cancer (BC) in the European population. Here, we investigated the association between BC and blood-based methylation of cluster of d
Externí odkaz:
https://doaj.org/article/9d189181eb4f4b16b3b56a96d66e7b07
Publikováno v:
Frontiers in cardiovascular medicine. 9
Coronary heart disease (CHD) brings a heavy burden to society worldwide. Novel and minimally invasive biomarkers for the risk evaluation of CHD are urgently needed. Previous study has revealed that blood-based hypomethylation of β-actin (We aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::95e2151757ed08be062c801cfc862082
https://pubmed.ncbi.nlm.nih.gov/36061541
https://pubmed.ncbi.nlm.nih.gov/36061541